1. Fischer A,
West SG,
Swigris JJ,
Brown KK,
du Bois RM.
Connective tissue disease-associated interstitial lung disease: a call for clarification.
CHEST 2010; 138:251–256.
2. Solomon JJ,
Olson AL,
Fischer A,
Bull T,
Brown KK,
Raghu G.
Scleroderma lung disease.
Eur Respir Rev 2013; 22:6–19.
3. Ioannidis JP,
Vlachoyiannopoulos PG,
Haidich AB et al.
Mortality in systemic sclerosis: an international meta-analysis of individual patient data.
Am J Med.
2005; 118:2-10.
4. Lynch DA.
Lung disease related to collagen vascular disease.
J Thorac Imaging.
2009; 24:299-309.
5. Santos MK,
Faria FB,
Trad CS.
Pulmonary involvement in systemic sclerosis: cases review.
Radiol Bras 2006; 39:181-184
6. Denton CP,
Khanna D.
Systemic sclerosis.
Lancet.
2017 Apr 13.
pii: S0140-6736(17)30933-9.
[Epub ahead of print]
7. Ferri C,
Colaci M,
Battolla L,
Giuggioli D,
Sebastiani M.
Thymus alterations and systemic sclerosis.
Rheumatology (Oxford).
2006 Jan;45(1):72-75.
8. Oksel F,
Tarhan F,
Bayraktaroğlu S,
et al.
Radiological incomplete thymus involution in systemic sclerosis,
Rheumatology 2009; 48: 800-803.
9. Bhalla M,
Silver RM,
Shepard JA,
McLoud TC.
Chest CT in patients with scleroderma: prevalence of asymptomatic esophageal dilatation and mediastinal lymphadenopathy.
AJR Am J Roentgenol 1993; 161:269-272.
9. Goh NS,
Desai SR,
Veeraraghavan S,
Hansell DM,
Copley SJ,
Maher TM,
et al.
Interstitial lung disease in systemic sclerosis: a simple staging system.
Am J Respir Crit Care Med 2008; 177:1248–1254.